O Hospital Nove de Julho é um hospital brasileiro da cidade de São Paulo. Fundado em 1955, por Antônio Ganme, João Ganme e Anis Ganme, que adquiriram o antigo Hospital Nossa Senhora da Conceição, na rua Peixoto Gomide, onde está até hoje.

During the past decade, Hospital Nove de Julho conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nove de Julho" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Hospital Israelita Albert Einstein" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Genova Inc." with 1 trials sponsored and "University of Manitoba" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nove de Julho" #1 collaborator was "CytoDyn, Inc." with 1 trials as a collaborator and "University Health Network, Toronto" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nove de Julho" are "Acute Coronary Syndrome" (1 trials), "Acute Respiratory Infection" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "COVID-19" (1 trials) and "COVID-19 Pneumonia" (1 trials). Many other conditions were trialed in "Hospital Nove de Julho" in a lesser frequency.

Most popular intervention types in "Hospital Nove de Julho" are "Drug" (9 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Lazertinib" (3 trials), "Amivantamab" (2 trials), "Carboplatin" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nove de Julho" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nove de Julho". undefined are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Nove de Julho, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nove de Julho, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".